Flecainide safety for heart patients with atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a heart rhythm drug called flecainide to see if it is safe for people who have both atrial fibrillation (an irregular heartbeat) and coronary artery disease (narrowed heart blood vessels). Participation could help doctors decide if this drug is a good treatment option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have atrial fibrillation or a related fast heartbeat that comes and goes, not permanent.
- You have been diagnosed with coronary artery disease (narrowing of heart arteries) or had a prior heart procedure like a stent or bypass surgery.
- Your heart pumps at least 45% of blood out (normal or mildly reduced function).
- You have not had a heart attack or heart surgery in the last 3 months.
- You have not had a bad reaction to flecainide or to both sotalol and amiodarone before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different treatment strategies for atrial fibrillation (an irregular heartbeat) in people who also have heart failure. One strategy uses medications only, while the other includes a procedure to restore normal heart rhythm. The goal is to find the best way to improve symptoms and outcomes.
This trial compares a procedure called ablation (using cold, heat, or electric pulses to fix irregular heartbeats) with standard medications to see which better treats heart failure in people who also have atrial fibrillation. It may help if your heart's pumping ability is reduced and you still have symptoms despite medications.
This study tests whether giving the medicine amiodarone before a scheduled electrical cardioversion (a procedure that shocks the heart back into rhythm) improves the chances of restoring a normal heartbeat in people with persistent atrial fibrillation. It compares outcomes with and without this pre-treatment.
This study compares two treatments for people with atrial fibrillation (an irregular heartbeat) and a specific type of heart failure. It looks at whether a procedure called catheter ablation (which uses heat to fix the heart's rhythm) works better than taking daily heart rhythm medications.
This trial tests two different catheters that use pulsed field energy to treat atrial fibrillation (a heart rhythm problem). It aims to find which one works better for people who need blood thinners but have a high risk of bleeding.
This study looks at how a person’s genetics may affect how well and safely antiarrhythmic medicines work for atrial fibrillation (AF). If you join, you may get medicine options like flecainide or sotalol, and researchers compare outcomes to genetic information.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.